NEUPHORIA THERAPEUTICS INC (NEUP) Stock Income Statement
NASDAQ:NEUP • US64136E1029
4.54 USD
+0.22 (+5.09%)
Last: Mar 9, 2026, 04:30 PM
| TTM (2025-12-31) | 2025 (2025-6-30) | 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 15.00M | 15.65M | 0.00 | 0.00 | 191.00K | |||
| Operating Expenses | 17.34M | 16.78M | 17.89M | 21.98M | 16.34M | |||
| Research and Development | 9.85M | 9.01M | 9.42M | 13.07M | 11.60M | |||
| Selling, General, and Administrative Expenses | 7.47M | 7.77M | 8.47M | 8.91M | 8.26M | |||
| Operating Income | -2.34M | -1.13M | -17.89M | -21.98M | -16.15M | |||
| Interest Income/Expense | -552.00K | -249.00K | 10.00K | 632.00K | 246.00K | |||
| Other Income/Expense | -1.96M | 540.00K | 2.30M | 423.00K | -13.00K | |||
| Non Recurring Items | N/A | N/A | N/A | -593.00K | 0.00 | |||
| Income Before Taxes | -6.08M | -838.00K | -15.58M | -21.52M | -15.92M | |||
| Income Tax | -417.60K | -468.00K | -87.00K | -139.00K | -139.00K | |||
| Net Income | -5.66M | -370.00K | -15.49M | -21.38M | -15.78M | |||
| EBITDA | -1.67M | -466.10K | -17.23M | -21.32M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -2.12 | -0.23 | -0.10 | -0.17 | -0.14 | |||
| Non GAAP EPS | N/A | N/A | N/A | N/A | -0.02 | |||
| Statistics | ||||||||
| Profit Margin | -37.76% | -2.36% | N/A | N/A | -8260.21% | |||
| Operating Profit Margin | -15.57% | -7.21% | N/A | N/A | -8454.45% | |||
All data in USD